Oct 7, 2017
Market Research Future published a research report on Peripheral Artery Disease Market. Which is Expecting Grow at CARG 6.5 % Forecast 2023

Pune, India - October 6, 2017 /MarketersMedia/ —
Global Peripheral artery disease Market Research Report, By devices (Stents, Angioplasty Balloon Catheters, Atherectomy Devices, and Other), By Drugs (Lipid-Lowering Drugs, Glucose Regulating Drug and Other), Types Of Diseases (Blood Clotting Disorders, Lymphedema, Atherosclerosis and Other)- Forecast Till 2023
Gastrointestinal (GI) drug market involves pharmacological and non-pharmacological Peripheral Artery Diseases is the condition in which there is narrowing of the arteries. This diseases affect the mostly affect legs. Deposition of cholesterol or plaques on the wall of arteries are responsible for the cause of the diseases. Population over 50 yr. are more susceptible for this diseases. Increasing population is the major reason for increasing the market of peripheral artery diseases. It was estimated that 20% of total population over 60 year age is suffering from peripheral artery diseases. Factors like obesity, diabetes and lifestyle habits like smoking and lack of exercise are the high risk factors for the development of this diseases. Increasing number of surgeries, number of different techniques and expectation to live more is increasing this market globally. Beside this introduction of generic medicines and many cheap options has increase the drug market. On other hand high cost associated with surgeries and lack of awareness amongst the general population may restrain the market growth.
Get a sample copy of this report at https://www.marketresearchfuture.com/sample_request/1540 .
North America and West Europe is the major contributor for the peripheral artery diseases market. Due to a huge aging population in this region is the major driving factor for the growth of the market. Besides increasing awareness in this region, high health care expenditure is the other driving factors for the market. As per study nearly 8 million of the people in US is suffering from major or minor peripheral artery diseases. Beside this nearly 15-20% of total North America population is suffering from diabetes, obesity, hypertensions. This disease are the major risk factor for development of peripheral artery disease. Asia Pacific region has a dominating population in the world. Increase in population is responsible for increase in patients for different diseases. Asia Pacific is the developing region and thus server a good platform to develop the market for different manufacturers. As per study 70% of population suffering from peripheral artery diseases is in middle and low income countries. And thus the Asia Pacific and Middle East region is expecting a good growth of the market. Simultaneously increasing smoking, diabetic population and people suffering from hypertension has a synergistic effect on the growth of the market. Asia Pacific region is growing at a CAGR of 8.5% during forecasted period of 2017-2023.
Global Peripheral artery disease Market is segmented into types of devices which includes Stents, angioplasty balloon catheters, Drug-Eluting Balloons, Atherectomy devices and other. Stents is further sub segmented into balloon-expandable and self-expandable. Atherectomy devices are further sub segmented into rotational, orbital, laser and directional.
By drugs they are segmented as Lipid-lowering drugs, blood pressure lowering drug, glucose regulating drug, clot preventing drug and other. By types of diseases they are segmented as Blood Clotting Disorders, Lymphedema, Atherosclerosis and Other
Browse Complete Report at https://www.marketresearchfuture.com/reports/peripheral-artery-disease-market-1540 .
Competitive Analysis
• Johnson & Johnson (U.S)
• Medtronic (Ireland)
• Sanofi S.A. (France)
• Abbott Laboratories (U.S)
• AstraZeneca Plc. (UK)
• Boston Scientific Corporation (U.S)
• Angioscore, Inc. (U.S)
• Bristol-Myers Squibb Company (US)
• Betagenon AB (Sweden)
• Proteon Therapeutics, Inc. (US)
• Merck & Co., Inc. (US)
• Bayer HealthCare Pharmaceuticals (Germany)
• Symic Bio, Inc. (US)
• CardioVascular BioTherapeutics, Inc. (US)
• nGes MG, Inc. (Japan)
• TheraVasc Inc. (US)
Study Objectives Global Peripheral artery disease Market
• Detail market analysis of global peripheral artery disease market with region and competitive analysis.
• Detail analysis of parent market and different drivers and restraints affecting the growth of the market.
• Detail Information about the present and forecasted market with its key players that influences the market on global scale.
• Analysis of the market of the different factors like- price analysis, supply chain analysis, porters five force analysis etc.
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global peripheral artery disease market.
• Detail information on the possible segments and sub segments of the market. And regional analysis of the market- North America, Europe, Asia Pacific and Middle East and Africa.
• Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Get a discount at https://www.marketresearchfuture.com/check-discount/1540 .
The report for Global Peripheral artery disease Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPES OF DEVICES
5.1 STENTS
5.1.1 BALLOON-EXPANDABLE
5.1.2 SELF-EXPANDABLE
5.2 ANGIOPLASTY BALLOON CATHETERS
5.3 DRUG-ELUTING BALLOONS
5.4 ATHERECTOMY DEVICES
5.4.1 ROTATIONAL
5.4.2 ORBITAL
5.4.3 LASER
5.4.4 DIRECTIONAL
5.5 OTHER
6. GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY DRUGS
6.1 LIPID-LOWERING DRUGS
6.2 BLOOD PRESSURE LOWERING DRUG
6.3 GLUCOSE REGULATING DRUG
6.4 CLOT PREVENTING DRUG AND OTHER.
Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Source URL: https://marketersmedia.com/peripheral-artery-disease-market-is-registering-a-cagr-of-6-5-by-2023/246817
For more information, please visit https://www.marketresearchfuture.com/reports/peripheral-artery-disease-market
Source: MarketersMedia
Release ID: 246817
President Volodymyr Zelensky of Ukraine said one soldier tried to kill himself when he was captured. “This is how they raise people in the North,” he said.
South Korean President Lee Jae Myung’s proposal for a phased approach to Pyongyang’s nuclear and missile programmes is a pragmatic response, analysts say, but prospects for gaining its arch-rival’s acceptance remain uncertain. In a keynote speech to the UN General Assembly on Tuesday, Lee laid out a long-term, step-by-step sequence for pursuing the ultimate goal of North Korea’s denuclearisation. He had called for Washington to ease sanctions in return for North Korea stopping its nuclear...
Secretary of State Marco Rubio said that U.S. negotiators had restarted conversations about Iran’s nuclear program, but that there were no breakthroughs.
Australia is exploring potential legal action after an artificial intelligence agent accessed nonpublic information on the country’s universal health care system.
Ma Yansong, China’s reigning starchitect, lets his buildings wrapped in nature do the shouting.
Toey Wattana Mongkhonnam began thinking about outfitting his family home in Thailand’s northeastern province of Yasothon with solar panels during the Covid-19 pandemic. In his household of five, electricity use rises with the day’s heat, and the monthly bill could range from 1,000 to 1,500 baht (US$30 to US$45). “Back then, I checked prices and a rooftop panel system that could put out enough power to run my household’s appliances could cost 100,000 to 200,000 baht,” said Toey, a Muay Thai...
An autonomous OpenAI programme infiltrated an Australian government health website in June in an “unacceptable” breach, Prime Minister Anthony Albanese said. The artificial intelligence agent accessed public and non-public files of the health statistics service, he told reporters in New York on Wednesday. OpenAI did not raise the alarm with the Australian government until September, when it sent an email outlining the incident to a generic email address. “Today I spoke with the CEO of OpenAI,...
Washington is increasingly turning to South Korea to ease ammunition supply bottlenecks triggered by wars in the Middle East and Europe, potentially accelerating Seoul’s integration into the US defence industrial base. Analysts say the United States may struggle to replenish stockpiles quickly enough if conflicts in Iran and Ukraine drag on, creating opportunities for South Korea’s defence industry to expand its presence in the US market. Jang Won-joon, a defence science professor at Jeonbuk...
Experts attribute the changing mood to fading memories of the coronavirus pandemic, awareness of China’s tech innovations and disaffection with President Trump’s trade wars.
Discussion about the Chinese leader’s health is heavily censored in China even as the 73-year-old is expected to remain in power.
A country’s diaspora can be a symbol of its pride and power. A nation’s diaspora can help it build international value through success stories, promote its soft power through culture and contribute to its economic progress through remittances, investments and transfers of expertise. India and China have among the world’s largest diasporas. They also offer two very different models of how countries can leverage their diasporas. In India, before the 1991 reforms, people mostly saw those who left...
An attack on a cargo ship in the Strait of Hormuz on Wednesday killed an Indian sailor, Omani and Indian authorities said, with the latter condemning the ongoing attacks in the vital shipping lane. Since the start of the Middle East war, Iran has sought to impose its control over the maritime conduit for Gulf oil and gas, occasionally striking ships accused of failing to coordinate with its authorities or deviating from its preferred route. In retaliation, the US has been enforcing a...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.